Jane Street Group, LLC Kala Pharmaceuticals, Inc. Call Options Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Aug 16, 2021	SELL	$5.06 - $8.15 $14,673 - $23,635	-2,900 Reduced 3.68%	76,000 $403,000
Q1 2021 May 18, 2021	SELL	$6.24 - $9.58 $220,272 - $338,174	-35,300 Reduced 30.91%	78,900 $532,000
Q4 2020 Feb 17, 2021	BUY	$6.28 - $8.79 $486,072 - $680,345	77,400 Added 210.33%	114,200 $774,000
Q3 2020 Nov 17, 2020	SELL	$7.5 - $11.11 $133,500 - $197,758	-17,800 Reduced 32.6%	36,800 $276,000
Q2 2020 Aug 17, 2020	BUY	$8.33 - $13.79 $134,946 - $223,398	16,200 Added 42.19%	54,600 $574,000
Q1 2020 May 15, 2020	BUY	$3.83 - $8.79 $147,072 - $337,535	38,400 New	38,400 $338,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $9.96M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.